Research ArticleClinical Studies
Seizures Prior to Radiotherapy of Gliomas: Prevalence, Risk Factors and Survival Prognosis
JASPAR WITTELER, TROELS W. KJAER, SOEREN TVILSTED, STEVEN E. SCHILD and DIRK RADES
Anticancer Research July 2020, 40 (7) 3961-3965; DOI: https://doi.org/10.21873/anticanres.14388
JASPAR WITTELER
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
TROELS W. KJAER
2Neurological Department, Zealand University Hospital, Roskilde, Denmark
SOEREN TVILSTED
3Research Projects and Clinical Optimization, Zealand University Hospital, Koege, Denmark
STEVEN E. SCHILD
4Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
In this issue
Seizures Prior to Radiotherapy of Gliomas: Prevalence, Risk Factors and Survival Prognosis
JASPAR WITTELER, TROELS W. KJAER, SOEREN TVILSTED, STEVEN E. SCHILD, DIRK RADES
Anticancer Research Jul 2020, 40 (7) 3961-3965; DOI: 10.21873/anticanres.14388
Jump to section
Related Articles
- No related articles found.
Cited By...
- Increasing Seizure Activity During Radiation Treatment for High-grade Gliomas - Final Results of a Prospective Interventional Study
- Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival
- Re-Evaluation of Prognostic Factors for Survival After Radiotherapy of Cerebral Gliomas: A Supplementary Analysis to a Previous Study
- Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas